Advanced Plant Pharmaceuticals, Inc.'s Majority Owned Subsidiary, Mazal Plant Pharmaceuticals Inc., Receives Investigational New Drug Application Approval from the FDA for HDL/Cholesterol Improvement Drug
19. Mai 2005 09:49 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, May 19, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc., announced today that Mazal received...
Advanced Plant Pharmaceuticals and Subsidiary, Mazal Plant Pharmaceuticals Inc., File Investigational New Drug Application with FDA for Cholesterol-Lowering Drug
14. April 2005 12:09 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, April 14, 2005 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and its majority owned subsidiary, Mazal Plant Pharmaceuticals Inc., announced today that Mazal has filed an...
Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc.
01. März 2005 11:23 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, March 1, 2005 (PRIMEZONE) -- David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc., (OTCBB:APPI) announced today the appointment of Dr. Mechael Kanovsky as President of Mazal Plant...
Advanced Plant Pharmaceuticals Acquires 99 Percent of Mazal Plant Pharmaceuticals Inc., a Company Focused on Developing Three Drugs for FDA Approval Process.
01. Dezember 2004 09:27 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, Dec. 1, 2004 (PRIMEZONE) -- David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc., (OTCBB:APPI) confirmed today the closing of an asset sale agreement entered with Mazal Plant...
Advanced Plant Pharmaceuticals, Inc. Retains NAC Marketing to Spearhead Lo-Chol Campaign
07. September 2004 09:15 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, Sept. 7, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI), a company dedicated to the research, development and marketing of "whole plant" nutraceuticals and...
Advanced Plant Pharmaceuticals, Inc. Appoints Dr. Mechael Kanovsky to Coordinate Pharmaceutical Drug Development Activities
26. August 2004 14:12 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, Aug. 26, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI) announced today that it has appointed Dr. Mechael Kanovsky to spearhead the Company's recently...
Advanced Plant Pharmaceuticals, Inc. Discontinues Relationship with GMP
19. August 2004 11:54 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, Aug. 19, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. ("APPI") (OTCBB:APPI), a company dedicated to the research, development and marketing of "whole plant" nutraceuticals and...
Advanced Plant Pharmaceuticals, Inc. Successfully Delisted from Berlin-Bremen Stock Exchange
03. Juni 2004 12:55 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, June 3, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) announced today that it had successfully been delisted from the Berlin-Bremen Stock Exchange. The company had...
Advanced Plant Pharmaceuticals, Inc. Files 10-KSB
15. April 2004 13:49 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, April 15, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI), a company that utilizes whole plants through a proprietary (patent pending) manufacturing process to develop...
Advanced Plant Pharmaceuticals, Inc. Listed on the Berlin Exchange
22. März 2004 14:15 ET
|
Advanced Plant Pharmaceuticals, Inc.
NEW YORK, March 22, 2004 (PRIMEZONE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) is pleased to announce that it has been listed on the Berlin Stock Exchange. The trading symbol on the Berlin...